Biliary Stents Market Size & Growth Forecast 2026–2035, By Segments (Type, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Biliary Stents Market size was valued at USD 153.78 Million in 2025 and is anticipated to grow at a 5.2% CAGR from 2026 to 2035, reaching USD 255.3 Million by 2035. The industry revenue for 2026 is calculated at USD 160.71 million.
Get more details on this report
Request Free Sample ReportBiliary Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to established endoscopy infrastructure, broad access to minimally invasive biliary procedures, specialist availability, and consistently high procedural volumes across hospitals and gastroenterology centers.
- Asia Pacific is projected to grow at a 5.88% CAGR, supported by expanding hospital capabilities, greater access to endoscopic interventions, and increasing uptake of gastrointestinal and hepatobiliary care.
Segment Momentum
- Metal biliary stents held a 64.98% market share in 2025 due to their longer patency, durability, and reduced replacement frequency, helping providers improve procedural efficiency and manage biliary obstruction with fewer repeat interventions.
- Ambulatory Surgical Centers are growing fastest as more suitable biliary procedures move to outpatient settings that offer streamlined workflows, shorter stays, and efficient treatment pathways for minimally invasive interventions.
Market Expansion Drivers
- Rising prevalence of biliary disorders and chronic liver diseases increasing interventional treatment demand.
- Expanding adoption of endoscopic luminal stenting for malignant and non-neoplastic biliary obstructions.
- Advancements in drug-eluting and self-expanding stent technologies improving procedural outcomes and durability.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key players in the biliary stents market include Boston Scientific Corporation (United States), Cook Medical LLC (United States), Olympus Corporation (Japan), Becton, Dickinson and Company (United States), Medtronic plc (Ireland), Teleflex Incorporated (United States), ConMed Corporation (United States), Taewoong Medical Co., Ltd. (South Korea), Merit Medical Systems, Inc. (United States), Micro-Tech (Nanjing) Co., Ltd. (China).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
A growing patient pool with biliary strictures, obstructive jaundice, gallstone-related complications, and liver disease–associated biliary impairment is steadily increasing demand for the biliary stents market, as more cases progress to conditions that require decompression or sustained ductal patency rather than drug therapy alone. In practice, This transitions treatment volumes toward gastroenterology and hepatobiliary intervention pathways, where stenting becomes part of routine management for symptom relief, drainage, and prevention of recurrent obstruction. That clinical dependence on minimally invasive biliary access is contributing to market size growth by increasing procedural frequency and reinforcing recurring product use in both initial placement and replacement settings.
Expanding adoption of endoscopic luminal stenting for malignant and non-neoplastic biliary obstructions
Greater use of endoscopic stenting is strengthening development of the biliary stents market because it aligns with how clinicians increasingly manage biliary obstruction: through less invasive, image-guided procedures that can relieve blockage without the burden of open surgical intervention. For malignant obstruction, this supports palliative drainage and continuity of cancer care, while in non-neoplastic disease it offers a practical route for managing benign strictures and post-surgical complications. As endoscopic retrograde techniques become more embedded in treatment algorithms and hospital workflow, device selection is influenced by ease of deployment, revision needs, and compatibility with repeat interventions, increasing market presence through routine procedural adoption.
Advancements in drug-eluting and self-expanding stent technologies improving procedural outcomes and durability
Technology improvements are influencing adoption in the biliary stents market by addressing two persistent clinical priorities: maintaining patency for longer periods and reducing the need for early reintervention. Self-expanding designs improve conformability and lumen support in narrowed ducts, while drug-eluting approaches are being developed to limit tissue ingrowth, biofilm formation, or restenosis that can shorten functional life. These performance gains affect purchasing and treatment decisions directly, since physicians and care centers weigh stent durability, deployment reliability, and follow-up burden when selecting devices, encouraging market growth toward higher-value products with stronger procedural utility.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of biliary disorders and chronic liver diseases increasing interventional treatment demand | 2.00% | Moderate | North America, Europe | High | Near Term |
| Expanding adoption of endoscopic luminal stenting for malignant and non-neoplastic biliary obstructions | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Advancements in drug-eluting and self-expanding stent technologies improving procedural outcomes and durability | 1.30% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the largest regional market share in 2025 for the biliary stents market, supported by established endoscopy infrastructure, broad availability of minimally invasive biliary procedures, and strong utilization across hospitals and specialized gastroenterology centers. The region’s leadership is aided by routine diagnosis and intervention for biliary obstruction, where clinicians can access advanced stent options and perform procedures within well-developed care pathways. This practical combination of procedural volume, specialist availability, and treatment access sustains consistent market demand across the regional healthcare system.
Asia Pacific is projected to expand at a 5.88% CAGR over the forecast period in the biliary stents market, propelled by rising procedural adoption as healthcare systems broaden access to gastrointestinal and hepatobiliary care. Growth is being accelerated by the expansion of hospital capabilities, increasing availability of endoscopic intervention, and stronger treatment uptake in markets where access to diagnosis and interventional management is improving. As more patients enter formal care settings and providers expand procedural capacity, regional demand for biliary stents is increasing through everyday clinical use.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Endoscopic Innovation FocusGermany continues adopting advanced biliary stents through strong utilization of endoscopic interventions in specialized healthcare facilities. Clinical preference is shifting toward devices that improve placement accuracy and reduce procedure-related complications.
France 🇫🇷
Clinical Device RefinementFrance prioritizes biliary stents that improve treatment efficiency and procedural safety within gastroenterology services. Healthcare providers continue evaluating advanced materials and designs that support effective biliary drainage procedures.
Italy 🇮🇹
Specialized Gastrointestinal CareItaly is strengthening biliary stent utilization through expanding access to specialized gastrointestinal and endoscopic treatment centers. Hospitals continue adopting modern stent solutions that enhance procedural consistency and patient management.
Japan 🇯🇵
Precision Gastroenterology CareJapan emphasizes high-quality biliary stents that support complex gastrointestinal procedures and reliable long-term performance. Healthcare institutions continue adopting refined stent designs suited to advanced endoscopic treatment practices.
South Korea 🇰🇷
Advanced Endoscopy AdoptionSouth Korea is expanding the use of biliary stents as hospitals invest in sophisticated endoscopic capabilities and minimally invasive care. Demand is supported by increasing availability of innovative stent technologies for complex biliary interventions.
United States 🇺🇸
Minimally Invasive ProceduresThe U.S. biliary stents market benefits from widespread adoption of minimally invasive endoscopic procedures for managing biliary disorders. Healthcare providers increasingly utilize advanced stent technologies that improve procedural efficiency and patient outcomes.
Segment Leadership and Growth Trends
Biliary Stents Market Share (%), Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMetal held a 64.98% share of the biliary stents market in 2025, reflecting its established role in procedures where longer patency and reduced need for frequent replacement remain important in routine clinical practice. Its leadership is underpinned by the practical preference for durable stenting solutions in managing biliary obstruction, particularly in settings where minimizing repeat interventions can improve procedural efficiency and patient management. That combination of clinical familiarity and operational reliability continues to support Metal’s leading share in the biliary stents market.
Polymer is the fastest-growing type in the biliary stents market as providers increasingly use it in cases where removability, procedural flexibility, and cost-conscious treatment pathways matter more than long-term permanence. Growth is being supported by its fit in shorter-term or more adaptable treatment strategies, especially where physicians value easier replacement and adjustment during follow-up care. Compared with metal alternatives, Polymer is gaining momentum because it aligns well with evolving procedural decision-making that favors practical, case-specific stent selection.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals accounted for the largest share of the biliary stents market in 2025, supported by their central role in handling complex biliary procedures, broader patient inflow, and access to the multidisciplinary infrastructure often required for diagnosis, intervention, and post-procedure management. Their leadership is sustained by the concentration of advanced endoscopic capabilities and specialist care within hospital settings, which makes them the primary treatment environment for a wide range of biliary obstruction cases. This care delivery model continues to preserve Hospitals’ leading share in the biliary stents market.
Ambulatory Surgical Centers are emerging as the fastest-growing end-use segment in the biliary stents market as healthcare delivery shifts toward more efficient outpatient procedural settings for suitable cases. Their momentum is tied to streamlined workflows, shorter stays, and growing acceptance of minimally invasive interventions outside traditional inpatient environments. Relative to hospitals, Ambulatory Surgical Centers are gaining ground where case selection allows safe and efficient treatment in lower-intensity care settings, making them well aligned with current procedural and operational preferences.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Metal, Polymer, Plastic | Metal | Polymer |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Application | Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Structures, Gallstones, Others | Gallstones | Benign Biliary Structures |
Competitive Landscape and Market Positioning
1. Boston Scientific Corporation (United States)
2. Cook Medical LLC (United States)
3. Olympus Corporation (Japan)
4. Becton Dickinson and Company (United States)
5. Medtronic plc (Ireland)
6. Teleflex Incorporated (United States)
7. ConMed Corporation (United States)
8. Taewoong Medical Co. Ltd. (South Korea)
9. Merit Medical Systems Inc. (United States)
10. Micro-Tech (Nanjing) Co. Ltd. (China)
The biliary stents market is witnessing advancements focused on improving procedural efficiency, patient recovery, and long-term stent performance. Manufacturers are introducing enhanced stent designs with improved flexibility, biocompatibility, and anti-migration features to address complex clinical requirements. Growing preference for minimally invasive treatments is also supporting innovation in the biliary stents market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| CGBIO | Jul-24 | CGBIO received product approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its ARISTENT biliary stents. This milestone facilitates the company’s commercial entry into the Japanese market and supports its broader strategy to accelerate global expansion through regulatory-backed product launches. |
| Olympus Corporation | Dec-25 | Olympus Corporation, W. L. Gore & Associates, and ConMed Corporation announced a transition in commercial support for the GORE VIABIL Biliary Endoprosthesis. Olympus assumed distribution duties in the U.S., integrating the stent into its established endotherapy sales network to strengthen its competitive position in the fully covered metal biliary stent segment. |
| TaeWoong Medical | May-26 | TaeWoong Medical USA received U.S. FDA 510(k) clearance for the Niti-S SPAXUS Stent. This fully covered, self-expanding metallic stent is designed for EUS-guided procedures, enabling a commercial launch in the U.S. that enhances the company’s portfolio for minimally invasive biliary drainage and therapeutic endoscopy. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Biliary Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Biliary Stents Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much is the biliary stents market worth?
What is the anticipated CAGR of the biliary stents industry?
How is the growing use of endoscopic biliary interventions influencing demand in the biliary stents market?
Why are advanced stent technologies becoming a key purchasing priority in the biliary stents market?
Why do metal biliary stents lead the biliary stents market?
Why are ambulatory surgical centers emerging as the fastest-growing end-use segment in the biliary stents market?
Why does North America lead the biliary stents market?
What is driving biliary stent market growth in Asia Pacific?
What are the key competitors in the biliary stents landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization